Treatment of Moderate Iron Deficiency Anemia in Pregnancy

Initial Treatment Approach

The American College of Cardiology is not mentioned, however, major guidelines recommend treating moderate iron deficiency anemia in pregnancy with 60-120 mg of elemental iron daily via oral supplementation, which is the first-line therapy, and should be started immediately upon diagnosis without waiting for additional confirmatory testing in pregnant women who are not acutely ill 1
The standard treatment regimen includes an elemental iron dose of 60-120 mg daily taken orally, as recommended by guidelines from the American Academy of Family Physicians 2, 1
Treatment should continue throughout pregnancy and the postpartum period to prevent recurrence, as suggested by the American College of Obstetricians and Gynecologists 1
Monitor response with repeat hemoglobin/hematocrit testing after 4 weeks of treatment, according to the guidelines from the American College of Obstetricians and Gynecologists 1

Counsel patients about iron-rich foods and dietary factors that enhance iron absorption, such as vitamin C, as recommended by the American Dietetic Association 1
Avoid concurrent calcium supplements and antacids, which decrease iron absorption; take these at different times of day, as suggested by the National Institutes of Health 3
Consider taking iron at bedtime to reduce gastrointestinal side effects, according to the guidelines from the American Gastroenterological Association 3

Vegetarian women require particular attention as their iron requirements may be almost twice as high due to lower absorption of non-heme iron from plant sources; consider higher supplementation doses in this population, as recommended by the Academy of Nutrition and Dietetics 1, 3
Higher-risk groups include non-Hispanic Black and Mexican American women, women with short intervals between pregnancies, and women with gastrointestinal disease or medications that decrease iron absorption, according to the guidelines from the Centers for Disease Control and Prevention 3 and the American Academy of Family Physicians 2

Before switching to IV iron, confirm compliance with oral iron and rule out other causes of anemia unresponsive to iron therapy, such as thalassemia minor or sickle cell trait, as recommended by the American College of Obstetricians and Gynecologists 1, 4
Treatment failure is defined as no response to oral iron after 4 weeks despite compliance with the regimen, according to the guidelines from the American College of Obstetricians and Gynecologists 4
If IV iron is indicated during pregnancy, ferric carboxymaltose is the preferred IV formulation due to rapid effectiveness and better tolerability, as suggested by the American Society of Hematology 4
IV iron administration should be performed in settings with resuscitation facilities available due to rare but serious allergic reactions, according to the guidelines from the American Academy of Allergy, Asthma, and Immunology 4

Monitor hemoglobin levels at 4-6 weeks postpartum in women at risk for persistent anemia to ensure adequate iron repletion, as recommended by the American College of Obstetricians and Gynecologists 1